Trials / Completed
CompletedNCT00510393
Drug Eluting Stents In The Critically Ischemic Lower Leg
The DESTINY Trial: a Prospective Randomized Multicenter Trial Comparing the Implant of a Drug Eluting Stent (XIENCE V, Abbott Vascular) vs. a Bare Metal Stent (MULTILINK VISION, Abbott Vascular) in the Critically Ischemic Lower Leg
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- Flanders Medical Research Program · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Destiny trial compares the use of bare metal stent systems with drug eluting stent systems in the treatment of infrapopliteal lesions in patients with Critical Limb Ischemia. It will be investigated whether there is a difference in 12 month angiographic patency of the stented area using the 2 different stent systems.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | XIENCE V everolimus eluting coronary stent system | |
| DEVICE | MULTILINK VISION coronary stent system |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2007-08-02
- Last updated
- 2010-12-02
Locations
5 sites across 3 countries: Belgium, France, Germany
Source: ClinicalTrials.gov record NCT00510393. Inclusion in this directory is not an endorsement.